On June 1, Michael Y. Wong, M.D., of Princeton Eye Group became the first doctor in central New Jersey to use a revolutionary new implant for cataract patients that restores both near and far vision.
August 9, 2005 (Press Release) --
On June 1, Michael Y. Wong, M.D., of Princeton Eye Group became the first doctor in central New Jersey to use the AcrySof® ReSTOR® Intraocular Lens (IOL), a revolutionary new implant for cataract patients that restores both near and far vision.
Approved on March 21, 2005 by the U. S. Food and Drug Administration (FDA), the ReSTOR IOL is the first and only IOL that uses apodized diffractive technology to provide cataract patients with and without presbyopia a quality range of vision. Presbyopia is the age-associated progressive loss of the focusing power of the lens, which results in difficulty seeing objects close-up.
The ReSTOR IOL represents the latest breakthrough in cataract treatment. Until recently, patients who underwent cataract surgery could expect improved distance vision. However, most still needed reading glasses to see objects such as menu and labels up close.
By comparison, the use of the ReSTOR IOL during cataract surgery results in a full range of vision. In clinical studies, 80% of patients who received the ReSTOR IOL reported that they no longer wear glasses for any activity.
The manufacturer, ALCON, Inc., selected Princeton Eye Group to debut this new technology to central New Jersey patients because of its highly qualified staff and long history pioneering eye care therapies.
“This ReSTOR IOL may very well revolutionize cataract surgery,” said Steven Felton, M.D., Ph.D., and founder of Princeton Eye Group. “I’m proud to say that Princeton Eye Group will be leading the way again in this technology.”
About 20.5 million Americans age 40 and older have cataracts, according to Prevent Blindness America’s 2002 Vision Problems in the U.S. report, and as many as 30.1 million Americans will have cataracts by 2020, the report estimated.
“The ReSTOR lens promises to reduce older individuals’ dependency on glasses, much like LASIK did for a younger age group,” said Dr. Wong.
About the Princeton Eye Group
Princeton Eye Group was one of the first practices in the area to adopt a holistic approach to eye care, bringing all the key players – ophthalmologists, optometrists and opticians – together under one roof.
It was also the first practice in central New Jersey to perform refractive surgery in the 1980s, the first to do intra-ocular lens cataract surgery and corneal ring segments, and the first to offer LASIK Laser Vision Correction and Custom LASIK to patients in the 1990s.
Today, Princeton Eye Group is one of the most distinguished and respected practices in Central Jersey, with three fully equipped locations and a highly trained staff with diverse backgrounds and areas of expertise.
Princeton Eye Group also maintains a strong relationship with Wills Eye Hospital of Philadelphia, ranked one of the top three eye hospitals in the world in survey after survey.
Princeton Eye Group is headquartered at 419 North Harrison Street in Princeton, and has fully equipped locations in Somerset and Monroe Township.
Approved on March 21, 2005 by the U. S. Food and Drug Administration (FDA), the ReSTOR IOL is the first and only IOL that uses apodized diffractive technology to provide cataract patients with and without presbyopia a quality range of vision. Presbyopia is the age-associated progressive loss of the focusing power of the lens, which results in difficulty seeing objects close-up.
The ReSTOR IOL represents the latest breakthrough in cataract treatment. Until recently, patients who underwent cataract surgery could expect improved distance vision. However, most still needed reading glasses to see objects such as menu and labels up close.
By comparison, the use of the ReSTOR IOL during cataract surgery results in a full range of vision. In clinical studies, 80% of patients who received the ReSTOR IOL reported that they no longer wear glasses for any activity.
The manufacturer, ALCON, Inc., selected Princeton Eye Group to debut this new technology to central New Jersey patients because of its highly qualified staff and long history pioneering eye care therapies.
“This ReSTOR IOL may very well revolutionize cataract surgery,” said Steven Felton, M.D., Ph.D., and founder of Princeton Eye Group. “I’m proud to say that Princeton Eye Group will be leading the way again in this technology.”
About 20.5 million Americans age 40 and older have cataracts, according to Prevent Blindness America’s 2002 Vision Problems in the U.S. report, and as many as 30.1 million Americans will have cataracts by 2020, the report estimated.
“The ReSTOR lens promises to reduce older individuals’ dependency on glasses, much like LASIK did for a younger age group,” said Dr. Wong.
About the Princeton Eye Group
Princeton Eye Group was one of the first practices in the area to adopt a holistic approach to eye care, bringing all the key players – ophthalmologists, optometrists and opticians – together under one roof.
It was also the first practice in central New Jersey to perform refractive surgery in the 1980s, the first to do intra-ocular lens cataract surgery and corneal ring segments, and the first to offer LASIK Laser Vision Correction and Custom LASIK to patients in the 1990s.
Today, Princeton Eye Group is one of the most distinguished and respected practices in Central Jersey, with three fully equipped locations and a highly trained staff with diverse backgrounds and areas of expertise.
Princeton Eye Group also maintains a strong relationship with Wills Eye Hospital of Philadelphia, ranked one of the top three eye hospitals in the world in survey after survey.
Princeton Eye Group is headquartered at 419 North Harrison Street in Princeton, and has fully equipped locations in Somerset and Monroe Township.
Email
Print
SPAM
USER COMMENTS
LEAVE A COMMENT
